Centers for Disease Control (CDC). (1987a). Recommendations for prevention of HIV transmission in health-care settings. Morbidity and Mortality Weekly Report, 36(2S), 1–18.
2.
Centers for Disease Control (CDC). (1987b). Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morbidity and Mortality Weekly Report, 37, 509–515.
3.
Centers for Disease Control (CDC). (1988). Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. Morbidity and Mortality Weekly Report, 37, 377–388.
4.
Centers for Disease Control (CDC). (1989). Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morbidity and Mortality Weekly Report, 38(S-6), 1–37.
5.
Centers for Disease Control (CDC). (1991). Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. Morbidity and Mortality Weekly Report, 39(RR-1), 1–11.
6.
Centers for Disease Control (CDC). (1991). Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report, 40(RR-13), 1–25.
7.
Centers for Disease Control (CDC). (1993). Technical guide on HIV counseling. Morbidity and Mortality Weekly Report, 42(RR-2), 11–17.
8.
Centers for Disease Control and Prevention (CDCP), Division of STD-HIV Prevention, Training and Education Branch. (1990). Pretest and Posttest HIV Antibody Counseling Guides, Rev. Unpublished training materials.
9.
GerberdingJ. (1993). Is antiretroviral treatment after percutaneous HIV exposure justified?Annals of Internal Medicine, 118, 979–980.
10.
GerberdingJ.L., & HendersonD.K. (1992). Management of occupational exposures to bloodborne pathogens: Hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clinical Infectious Diseases, 14, 1179–1185.
11.
Occupational Safety and Health Administration, Department of Labor. (1991). 29 CFR Part 1910.1030 Occupational Exposure to Bloodborne Pathogens; Final Rule. Federal Register, 56, 64004–64174.
12.
TokarsJ.I.MarcusR.CulverD.H.SchableC.A.McKibbenP.S.BandeaC.I., Bell, D.M., & CDC Cooperative Needlestick Surveillance Group. (1993). Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Annals of Internal Medicine, 118, 913–919.
